Sarah was devastated. So when, days later, her consultant rang her up offering a brand new injection – called Ozempic – that promised to treat her diabetes and help her shed the pounds ...

A whopping one in eight adults in the US have tried GLP-1 medications like Ozempic and Wegovy, but despite their massive popularity, many people taking the drug do so in secret. Certainly there ...

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

Semaglutide — the powerful ingredient behind Wegovy and Ozempic — has long been hailed a monumental breakthrough in the war on obesity and type 2 diabetes. But American doctors, who tracked ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

Customers can expect a rate hike up to 14 percent as employee welfare costs surge related to Ozempic and drugs like it.

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.99%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...